Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 425 of 3270 entries
View as:

Efficacy Study of Methotrexate to Treat Sarcoid-associated Uveitis

Phase: N/A Priority: Normal
NCT ID: NCT00918554 Org: User:
Start: 09/30/09 End: 08/31/10 Due: 08/31/11

Prospective Study of Patients With Rheumatoid Arthritis After the Age of 65

Phase: N/A Priority: Normal
NCT ID: NCT02686320 Org: User:
Start: 03/29/16 End: 07/03/23 Due: 07/03/24

Breast Cancer Prevention and Screening Membership

Phase: N/A Priority: Normal
NCT ID: NCT05258539 Org: User:
Start: 05/31/22 End: 04/01/32 Due: 04/01/33

Characterization of the Long-term Safety, Efficacy, and Pharmacodynamics Revestive® in the Management of Short Bowel Syndrome Pediatric Patients

Phase: N/A Priority: Normal
NCT ID: NCT03562130 Org: User:
Start: 07/02/18 End: 07/13/20 Due: 07/13/21

Early Oseltamivir Carboxylate Low Plasma Concentration in Patients Admitted to Intensive Care for Severe Influenza

Phase: N/A Priority: Normal
NCT ID: NCT05375864 Org: User:
Start: 12/01/22 End: 03/01/25 Due: 03/01/26

Efficacy of Cotrimoxazole as a De-escalation Treatment of Ventilator-Associated Pneumonia in Intensive Care Unit

Phase: N/A Priority: Normal
NCT ID: NCT05696093 Org: User:
Start: 10/19/23 End: 12/31/26 Due: 12/31/27

Evaluation of Dental Emergency Treatments During COVID19 Crisis

Phase: N/A Priority: Normal
NCT ID: NCT04354272 Org: User:
Start: 04/21/20 End: 05/18/20 Due: 05/18/21

Study of Leukocyte Populations in Patients With Chronic Inflammatory

Phase: N/A Priority: Normal
NCT ID: NCT04749875 Org: User:
Start: 03/01/21 End: 03/01/26 Due: 03/01/27

GastroIntestinal Panel in Kidney Transplant Patients

Phase: N/A Priority: Normal
NCT ID: NCT05722119 Org: User:
Start: 02/28/23 End: 09/30/24 Due: 09/30/25

Cancer as a complicATion in reCipients of Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Disease iNdiCation trEated in FRance and Canada?

Phase: N/A Priority: Normal
NCT ID: NCT06507800 Org: User:
Start: 09/01/24 End: 09/01/25 Due: 09/01/26

Safety and Efficacy of Gene Therapy of the Sickle Cell Disease by Transplantation of an Autologous CD34+ Enriched Cell Fraction That Contains CD34+ Cells Transduced ex Vivo With the GLOBE1 Lentiviral Vector Expressing the βAS3 Globin Gene in Patients With Sickle Cell Disease (DREPAGLOBE)

Phase: N/A Priority: Normal
NCT ID: NCT03964792 Org: User:
Start: 11/12/19 End: 01/31/24 Due: 01/31/25

Aldosterone Resistance in Preterm Infants

Phase: N/A Priority: Normal
NCT ID: NCT01176162 Org: User:
Start: 01/31/10 End: 12/31/13 Due: 12/31/14

Study of Coronary Calcification in Subjects With Autosomal Dominant Familial Hypercholesterolemia Heterozygous

Phase: N/A Priority: Normal
NCT ID: NCT03501875 Org: User:
Start: 05/15/18 End: 06/28/21 Due: 06/28/22

PREdisposition Genetical in Cardiac Insufficiency = Genetic Predisposition to Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT01113268 Org: User:
Start: 09/30/10 End: 08/23/23 Due: 08/23/24

Assessment of Dual Antiplatelet Therapy Versus Rivaroxaban In Atrial Fibrillation Patients Treated With Left Atrial Appendage Closure

Phase: N/A Priority: Normal
NCT ID: NCT03273322 Org: User:
Start: 09/13/17 End: 09/30/19 Due: 09/30/20

Photoprotection Habits in Patients With Vitiligo

Phase: N/A Priority: Normal
NCT ID: NCT03323125 Org: User:
Start: 10/16/17 End: 04/16/18 Due: 04/16/19

Observational Follow-up Study of Haplo-identical Transplants in Fanconi Disease

Phase: N/A Priority: Normal
NCT ID: NCT05903365 Org: User:
Start: 06/30/23 End: 03/31/28 Due: 03/31/29

Innovative Anti-pneumococcal Vaccine Strategies in Patients With ANCA-associated Vasculitis Receiving Rituximab Therapy

Phase: N/A Priority: Normal
NCT ID: NCT03069703 Org: User:
Start: 02/05/18 End: 11/21/21 Due: 11/21/22

Abdominal Adipose Tissue Distribution in Type 2 Diabetic Patients Treated During 6 Months With Pioglitazone or Insulin

Phase: N/A Priority: Normal
NCT ID: NCT00159211 Org: User:
Start: 05/31/05 End: 05/31/07 Due: 05/31/08

Therapeutic Effects of Transcranial Alternative Current Stimulation (tACS) in Chronic Post Stroke Hemianopia

Phase: N/A Priority: Normal
NCT ID: NCT04043689 Org: User:
Start: 12/22/20 End: 04/03/25 Due: 04/03/26

Efficacy and Safety of Ustekinumab, a Human Monoclonal Anti-IL-12/IL-23 Antibody, in Patients With Behçet Disease

Phase: N/A Priority: Normal
NCT ID: NCT02648581 Org: User:
Start: 06/14/17 End: 11/19/19 Due: 11/19/20

Sub-cutaneous Infliximab in Inflammatory Rheumatic Disease

Phase: N/A Priority: Normal
NCT ID: NCT05424926 Org: User:
Start: 02/24/23 End: 02/28/25 Due: 02/28/26

Evaluation of Efficacy and Tolerance of Cladribine in Symptomatic Pulmonary Langerhans Cell Histiocytosis

Phase: N/A Priority: Normal
NCT ID: NCT01473797 Org: User:
Start: 11/30/11 End: 04/30/22 Due: 04/30/23

Characterization of At-risk Population for Pre-sacral Tumor in CURRARINO Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00780117 Org: User:
Start: 06/30/08 End: 12/31/11 Due: 12/31/12

Circulating Fetal Cells and Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04903990 Org: User:
Start: 05/14/21 End: 05/31/25 Due: 05/31/26